880263-00-3

Upstream product

• 1421-65-4 L-dopa methyl ester hydrochloride 
• 67561-03-9 N-benzyloxycarbonylglycinal 
• 880262-98-6 (1R,3S)-1-(Benzyloxycarbonylamino-methyl)-6,7-dihydroxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid methyl ester 
• 880262-99-7 (1R,3S)-1-(Benzyloxycarbonylamino-methyl)-2-formyl-6,7-dihydroxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid methyl ester 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 880263-02-5 ((1R,3S)-3-Hydroxymethyl-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinolin-1-ylmethyl)-carbamic acid benzyl ester 
• 880262-78-2 C₃₂H₃₅N₃O₆ 
• 880263-05-8 C₃₂H₃₅N₃O₇ 
• 880263-03-6 [2-[1-(benzyloxycarbonylamino-methyl)-3-hydroxymethyl-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]-1-(3,4-dimethoxy-benzyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester 
• 880262-81-7 C₃₂H₃₄N₄O₈ 
• 880262-80-6 C₃₂H₃₄ClN₃O₆ 
• 880262-86-2 C₃₂H₃₄ClN₃O₆ 
• 880263-06-9 C₃₃H₃₇N₃O₇ 

Relevant academic research and scientific papers

Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs

Two series of simplified analogs of the ecteinascidin-saframycin type alkaloids were prepared from l-DOPA. Their in vitro antitumor activity was tested against three human cancer cell lines (HCT-8 colon carcinoma, Bel-7402 liver carcinoma, and BGC-823 gas